Rosenblatt reiterates Palantir stock Buy rating on missile defense contract potential

Rosenblatt reiterated a Buy on Palantir with a $200 price target and estimates the Golden Dome phase-one program (now $185B, +50% vs $125B) could deliver Palantir ‘billions’ in contracts. Rosenblatt projects $18.2B of government revenue for 2026–2028 vs Street $13.6B, while Wedbush and Mizuho maintain $230 and $195 targets respectively; 17 analysts have raised estimates. Palantir trades at a $370B market cap with a P/E of 247 and InvestingPro flags it as overvalued versus fair value. Additional partnerships across mortgage ops, ISR and an energy deal with Centrus (potential $300M savings) underpin upside to estimates but remain execution-sensitive.

Analysis

The reported program thrusts software-first vendors (Palantir, Anduril, Ondas) toward prime-level economics, but the real structural winner will be firms that lock in integration and data-access at the platform layer — expect downstream recurring revenue and higher switching costs, not just one-off contract GTV. Semiconductor and space-comm suppliers (edge AI accelerators, satcom, low-SWaP sensors) are a second-order beneficiary; shortages or single-vendor dependencies could create months-long bottlenecks that re-price implementation schedules.

Valuation and timing are the key risks: a multi-year, multi-phase defense program creates lumpy booking cadence and binary event risk — budget appropriations, milestone certifications, or cybersecurity incidents can move multiples far faster than revenue recognition. Market consensus appears to be front-running awards; that raises dispersion risk between headline wins and actual funded milestones, which are the only things that drive material cash flow for our portfolio.

Competitive dynamics favor incumbents who can offer end-to-end C2 + sustainment; smaller partners will need equity-like upside to justify execution risk, increasing probability of M&A or unfavorable earn-outs. Politico-regulatory shocks (export controls, hearings, program rescopes) are the highest probability catalysts to reverse sentiment within 3–12 months, while a contract award cadence and FY26–28 bookings are the most reliable positive catalysts to re-rate the group over 12–36 months.

Key Decisions for Investors

• Directional, event-timed (convex): Buy a Jan-2028 LEAP call spread on PLTR sized 0.5–1% of fund NAV (buy longer-dated call, sell nearer-dated call to finance). Rationale: captures upside if funded milestones are confirmed and FY26–28 revenue beats; risk limited to premium, targeted asymmetry ~3–4x if market re-rates on booked revenue. Timeframe: 12–30 months to capture program execution and political runway.
• Downside protection: Buy 9–12 month protective puts on PLTR sized to cover 20% of the long-equity exposure (or purchase a put calendar). Rationale: insures against schedule slips, cybersecurity failures, or abrupt political/regulatory headwinds that compress multiples. Cost should be treated as insurance (expect 3–6% drag if purchased at current volatilities).
• Idiosyncratic growth play on supplier / partner: Initiate a tactical long in LEU (Centrus) overweight 0.3–0.7% NAV or buy 12–18 month calls. Rationale: pure project-level upside from enrichment/processing projects is less subject to tech multiple compression and can deliver 30–50% upside if cost savings and volumes materialize. Timeframe: 6–24 months tied to deployment milestones and realized cost-savings announcements.
• High-risk / high-reward small-cap exposure: Buy ONDS (Ondas) June-2027 calls sized 0.2–0.5% NAV or initiate a small outright position. Rationale: asymmetric payoff if ONDS secures integration work; high failure rate so keep size limited. Exit/scale rules: trim 50% on 50% move and stop-loss at 40% drawdown.